Practice

Diligence and valuation

A valuation with every method, weight and assumption shown.

Around ninety due-diligence reports for a single venture mandate since 2022, across digital health, clinical AI, genomics, devices and fintech, in eight jurisdictions — all under one assessment framework covering team, market, technology, traction and funding, with an independent investment view at the front.

The framework is the point. A report that cannot be compared with the last forty is an opinion; a report produced under a stated method is evidence. The same discipline runs through the valuation work — DCF, comparables and precedent transactions, weighted by stage, with the workings visible.

Scope

Venture due diligence at volume, under one framework
DCF, trading and transaction comparables, precedent transactions
Cap table, SAFE and convertible-instrument review
Fund-side pre-diligence and portfolio triage
Financial modelling for fundraising and board use

Before you talk to us

Run a free valuation and pre-diligence check

Five methods blended by stage, plus a Companies House cross-check for UK companies.

Open the tool →